Alere Stock Hits New 52-Week Low (ALR)

NEW YORK ( TheStreet) -- Alere (NYSE: ALR) hit a new 52-week low Monday as it is currently trading at $17.73, below its previous 52-week low of $17.76 with 218,734 shares traded as of 2:13 p.m. ET. Average volume has been one million shares over the past 30 days.

Alere has a market cap of $1.46 billion and is part of the health care sector and health services industry. Shares are down 20.4% year to date as of the close of trading on Friday.

Alere Inc. develops and manufactures patient diagnosis, monitoring, and health management products and services for cardiology, infectious diseases, toxicology, diabetes, oncology, and women's health in the United States and internationally.

TheStreet Ratings rates Alere as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and generally poor debt management. You can view the full Alere Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

FTC Approves Abbott's Acquisition of Alere, Stock Jumps

FTC Approves Abbott's Acquisition of Alere, Stock Jumps

These Stocks Are Ready to Reverse Course

These Stocks Are Ready to Reverse Course

Abbott CEO: Another Alere-Related Divestiture Coming Soon

Abbott CEO: Another Alere-Related Divestiture Coming Soon

Alere, St. Jude Deals in Focus as Abbott Releases Q2 Earnings

Alere, St. Jude Deals in Focus as Abbott Releases Q2 Earnings

Quidel Diversifies With Alere's Triage Assets

Quidel Diversifies With Alere's Triage Assets